Laboratorios Farmaceuticos Rovi, S.A. (LON:0ILL)
London
· Delayed Price · Currency is GBP · Price in EUR 55.76
+0.56 (1.02%)
At close: Jun 9, 2025
LON:0ILL Revenue
Laboratorios Farmaceuticos Rovi had revenue of 154.89M EUR in the quarter ending March 31, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 767.47M, down -1.49% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
767.47M EUR
Revenue Growth
-1.49%
P/S Ratio
3.87
Revenue / Employee
349.32K EUR
Employees
2,197
Market Cap
2.48B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Laboratorios Farmaceuticos Rovi News
- 3 months ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus
- 3 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call Transcript - Seeking Alpha